LASKY, Joseph, A.;ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND;SIDES, Mark, D.
发明人:
SIDES, Mark, D.,LASKY, Joseph, A.
申请号：
USUS2012/032634
公开号：
WO2012/139068A9
申请日:
2012.04.06
申请国别(地区):
US
年份:
2013
代理人:
摘要：
It has now been discovered that arsenic induces herpes viruses latent in infected cells to reactivate to the lytic stage. Herpes viruses in the lytic stage activate anti-herpes virus anti viral agents. Co-administration of arsenic compounds and anti-herpes viral agents to a population of cells infected with a herpes virus results in the death of the cells and inhibits proliferation of the virus. The invention is therefore useful for reducing a subject's population of cells infected with herpes viruses, particularly Epstein-Barr virus.
